Lactobacillus rhamnosus R0343ND and No Significant Change in Gastrointestinal Symptoms

• Tolerance and safety of the potentially probiotic strain Lactobacillus rhamnosus PRSF-L477: a randomised, double-blind placebo-controlled trial in healthy volunteers

  • 2010-08-09
  • RCT · n = 34
  • British Journal of Nutrition 104(12)
  • • R. D. Wind
    • Hermien Tolboom
    • I. Klare
    • G. Huys
    • J. Knol

  • PubMed: 20691131
  • DOI: 10.1017/S0007114510002746

  19 Insights on

  • No Significant Change in Gastrointestinal Symptoms

  • High evidence

  The recorded gastrointestinal symptoms, defecation frequency and stool consistency were not influenced indicating that L. rhamnosus PRSF-L477 was well tolerated.

  Effect

  Neutral

  Effect size

  Small